Stakeholders Urge Congress to Advance Antibiotic Development

COVID-19 response legislation should include economic incentives, funds for stewardship in hospitals

Stakeholders Urge Congress to Advance Antibiotic Development

The Pew Charitable Trusts, the Infectious Diseases Society of America, and dozens of other nonprofit and industry stakeholder groups sent a letter to Congress on May 8 encouraging lawmakers to enact a package of economic incentives in its next COVID-19 emergency relief package to stabilize the failing antibiotic market and address the challenges that hinder antibiotic development.

The organizations note that any such incentives must be paired with efforts to ensure that these drugs are used appropriately, including provision of federal funding to help hospitals establish antibiotic stewardship programs and report use and resistance data to the Centers for Disease Control and Prevention.

The front facade of the Supreme Court of the United States in Washington, DC.
ian-hutchinson-U8WfiRpsQ7Y-unsplash.jpg_master

Agenda for America

Resources for federal, state, and local decision-makers

Quick View

Data-driven policymaking is not just a tool for finding new solutions for emerging challenges, it makes government more effective and better able to serve the public interest.

Lightbulbs
Lightbulbs

States of Innovation

Data-driven state policy innovations across America

Quick View

Data-driven policymaking is not just a tool for finding new solutions for difficult challenges. When states serve their traditional role as laboratories of innovation, they increase the American people’s confidence that the government they choose—no matter the size—can be effective, responsive, and in the public interest.